Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Journal of the National Cancer Center|April 23, 2025
A novel risk stratification system for primary small-cell carcinoma of the esophagus: indication for prognostication and stagingYong Yang, Jing Yu, Silin Chen, et al.
National Science Review|July 24, 2023
Observation of Mott instability at the valence transition of f-electron systemHaifeng Yang, Jingjing Gao, Yingying Cao, et al.
Frontiers in Immunology|August 12, 2025
Impact of first-line chemoimmunotherapy with or without radiotherapy on the prognosis of patients with locally advanced or metastatic esophageal squamous cell carcinoma: a multicenter, real-world, retrospective cohort study from China (NCT06478355)Xinyi Liu, Jingyuan Wen, Yaowen Zhang, et al.
Therapeutic Advances in Medical Oncology|November 20, 2024
Effectiveness and safety of first-line pembrolizumab plus chemotherapy in patients with advanced/recurrent or metastatic esophageal squamous cell carcinoma in China: a real-world multicenter studyYu Lin, Wenbin Shen, Jinjun Ye, et al.
Nature Communications|July 24, 2023
Giant uniaxial negative thermal expansion in FeZr2 alloy over a wide temperature rangeMeng Xu, Qiang Li, Yuzhu Song, et al.
Radiation Oncology (London, England)|November 13, 2025
Validation and refinement of the 8th edition of the AJCC staging system for esophageal squamous cell carcinoma treated with definitive IMRT or chemo-IMRT: a Chinese multi-institutional retrospective studyYuanji Xu, Jiao Li, Xin Wang, et al.
Cancer Immunology, Immunotherapy : CII|November 18, 2025
Comparative analysis of immunochemotherapy with versus without radiation therapy for stage IVB esophageal squamous cell carcinoma confined to non-regional nodal metastases: a multicenter propensity score matching studyQi Liu, Junqiang Chen, Yuanji Xu, et al.
Nature Communications|February 17, 2024
Tunable positions of Weyl nodes via magnetism and pressure in the ferromagnetic Weyl semimetal CeAlSiErjian Cheng, Limin Yan, Xianbiao Shi, et al.
Nature Communications|November 3, 2025
Camrelizumab plus chemotherapy versus chemoradiotherapy as neoadjuvant therapy for resectable esophageal squamous cell carcinoma: Phase 2 randomized trial (REVO)Peiyuan Wang, Yujie Chen, Feng Wang, et al.
Pageof 10